Lisa Gill
Stock Analyst at JP Morgan
(3.22)
# 1,026
Out of 4,876 analysts
137
Total ratings
47.19%
Success rate
1.48%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Overweight | $405 → $418 | $302.62 | +38.13% | 8 | Jun 20, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $29 → $32 | $22.00 | +45.45% | 5 | May 28, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $180 → $190 | $177.06 | +7.31% | 3 | May 6, 2025 | |
| CON Concentra Group Holdings Parent | Maintains: Overweight | $29 → $30 | $20.69 | +45.00% | 2 | Mar 19, 2025 | |
| OPCH Option Care Health | Maintains: Overweight | $40 → $41 | $31.98 | +28.23% | 4 | Mar 6, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $14 → $17 | $13.76 | +23.55% | 4 | Mar 6, 2025 | |
| HUM Humana | Maintains: Neutral | $257 → $256 | $239.90 | +6.71% | 6 | Feb 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $80 → $81 | $68.14 | +18.87% | 5 | Feb 18, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $142 → $145 | $165.61 | -12.44% | 6 | Feb 4, 2025 | |
| COR Cencora | Maintains: Overweight | $289 → $301 | $296.58 | +1.49% | 2 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $12.85 | +40.08% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $3.86 | +29.53% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $21.70 | +29.03% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $15 | $11.38 | +31.81% | 14 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $8.05 | +11.80% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $22 → $18 | $8.34 | +115.83% | 4 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $656 → $661 | $722.00 | -8.45% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $438 | $330.00 | +32.73% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $13.31 | +35.24% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $291.06 | +35.71% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $243 | $256.98 | -5.44% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $177.43 | +4.83% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $172.56 | -18.87% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $377.66 | -12.09% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $628 → $631 | $373.18 | +69.09% | 4 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $7 → $10 | $4.93 | +102.84% | 1 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $2.31 | +289.61% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $4.82 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $5.09 | +57.17% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $73.19 | +13.40% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $53.57 | +82.94% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $21.80 | - | 4 | Dec 19, 2017 |
UnitedHealth Group
Jun 20, 2025
Maintains: Overweight
Price Target: $405 → $418
Current: $302.62
Upside: +38.13%
Privia Health Group
May 28, 2025
Maintains: Overweight
Price Target: $29 → $32
Current: $22.00
Upside: +45.45%
Quest Diagnostics
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $177.06
Upside: +7.31%
Concentra Group Holdings Parent
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $20.69
Upside: +45.00%
Option Care Health
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $31.98
Upside: +28.23%
Alignment Healthcare
Mar 6, 2025
Maintains: Neutral
Price Target: $14 → $17
Current: $13.76
Upside: +23.55%
Humana
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $239.90
Upside: +6.71%
CVS Health
Feb 18, 2025
Maintains: Overweight
Price Target: $80 → $81
Current: $68.14
Upside: +18.87%
Cardinal Health
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $165.61
Upside: -12.44%
Cencora
Jan 24, 2025
Maintains: Overweight
Price Target: $289 → $301
Current: $296.58
Upside: +1.49%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $12.85
Upside: +40.08%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $3.86
Upside: +29.53%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $21.70
Upside: +29.03%
Aug 30, 2024
Maintains: Overweight
Price Target: $20 → $15
Current: $11.38
Upside: +31.81%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $8.05
Upside: +11.80%
Aug 21, 2024
Maintains: Underweight
Price Target: $22 → $18
Current: $8.34
Upside: +115.83%
Aug 21, 2024
Maintains: Overweight
Price Target: $656 → $661
Current: $722.00
Upside: -8.45%
Aug 21, 2024
Maintains: Overweight
Price Target: $435 → $438
Current: $330.00
Upside: +32.73%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $13.31
Upside: +35.24%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $291.06
Upside: +35.71%
May 30, 2024
Maintains: Overweight
Price Target: $261 → $243
Current: $256.98
Upside: -5.44%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $177.43
Upside: +4.83%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $172.56
Upside: -18.87%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $377.66
Upside: -12.09%
May 30, 2024
Maintains: Overweight
Price Target: $628 → $631
Current: $373.18
Upside: +69.09%
Mar 1, 2024
Upgrades: Overweight
Price Target: $7 → $10
Current: $4.93
Upside: +102.84%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $2.31
Upside: +289.61%
Dec 13, 2023
Downgrades: Underweight
Price Target: n/a
Current: $4.82
Upside: -
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $5.09
Upside: +57.17%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $73.19
Upside: +13.40%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $53.57
Upside: +82.94%
Dec 19, 2017
Downgrades: Neutral
Price Target: n/a
Current: $21.80
Upside: -